GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Lummy Pharmaceutical (SZSE:300006) » Definitions » Effective Interest Rate on Debt %

Chongqing Lummy Pharmaceutical (SZSE:300006) Effective Interest Rate on Debt % : 3.39% (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Chongqing Lummy Pharmaceutical Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Chongqing Lummy Pharmaceutical's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was ¥14.3 Mil. Chongqing Lummy Pharmaceutical's average total debt for the quarter that ended in Mar. 2025 was ¥423.3 Mil. Therefore, Chongqing Lummy Pharmaceutical's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 3.39%.


Chongqing Lummy Pharmaceutical Effective Interest Rate on Debt % Historical Data

The historical data trend for Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Lummy Pharmaceutical Effective Interest Rate on Debt % Chart

Chongqing Lummy Pharmaceutical Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.89 4.71 7.27 3.92 2.91

Chongqing Lummy Pharmaceutical Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.67 3.54 3.48 2.90 3.39

Competitive Comparison of Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt %

For the Drug Manufacturers - General subindustry, Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt % falls into.


;
;

Chongqing Lummy Pharmaceutical Effective Interest Rate on Debt % Calculation

Chongqing Lummy Pharmaceutical's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2023 )+Total Debt  (A: Dec. 2024 ))/ count )
=-1  *  -11.131/( (270.787+494.594)/ 2 )
=-1  *  -11.131/382.6905
=2.91 %

where

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=129.027 + 141.76
=270.787

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=145.276 + 349.318
=494.594

Chongqing Lummy Pharmaceutical's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2024 )+Total Debt  (Q: Mar. 2025 ))/ count )
=-1  *  -14.344/( (494.594+351.998)/ 2 )
=-1  *  -14.344/423.296
=3.39 %

where

Total Debt  (Q: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=145.276 + 349.318
=494.594

Total Debt  (Q: Mar. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=119.826 + 232.172
=351.998

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Chongqing Lummy Pharmaceutical  (SZSE:300006) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Chongqing Lummy Pharmaceutical Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Chongqing Lummy Pharmaceutical's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Chongqing Lummy Pharmaceutical Business Description

Traded in Other Exchanges
N/A
Address
99 Yuma Road, Nan'an District, chongqing, CHN, 401123
Chongqing Lummy Pharmaceutical is a wholly-owned subsidiary of Lai America Pharmaceutical Co., Ltd. and is a professional pharmaceutical sales company in China.
Executives
Lai Wen Executives
Yuan Yuan Supervisors
Qiu Yu Directors, executives
Leng Xue Feng Secretary, Director
Zhang Xiao Xue Supervisors
Wang Ying Director
Zhou Xue Mei Supervisors
Zhao Bin Executives
Tang Xiao Hai Executives
Fu Rong Executives
Li Xian Feng Supervisors
Qiu Wei Director

Chongqing Lummy Pharmaceutical Headlines

No Headlines